Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer.
AuteursCaptier N, Lerousseau M, Orlhac F, Hovhannisyan-Baghdasarian N, Luporsi M, Woff E, Lagha S, Salamoun Feghali P, Lonjou C, Beaulaton C, Zinovyev A, Salmon H, Walter T, Buvat I, Girard N, Barillot E
Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.
AuteursId Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, Body JJ, Journé F
ASTRO Guidelines for Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer: A Disturbing Change of Paradigm for Intraoperative Radiation Therapy. Editorial on Behalf of the International Society of Intraoperative Radiation Therapy Working Group.
AuteursFastner G, Larsen S, Roeder F, Leonardi MC, Desmet A, Grecula J, Philippson C
Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial.
AuteursMetzger Filho O, Cardoso F, Poncet C, Desmedt C, Linn S, Wesseling J, Hilbers F, Delaloge S, Pierga JY, Brain E, Vrijaldenhoven S, Neijenhuis PA, Rutgers EJT, Piccart M, van 't Veer LJ, Viale G
Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship.
AuteursBorea R, Arecco L, Nardin S, Chiappe E, Lanzavecchia C, Fragío Gil M, Meacci A, Pham Hoang G, Nardin Weis L, de Moura Leite L, Klocker VE, Freire P, Brunetti N, Trevisan L, Buzzatti G, Spinaci S, Lambertini M